A Phase 3 Clinical Study of KHK4827
Phase 3
- Conditions
- Psoriasis
- Registration Number
- JPRN-jRCT2080222380
- Lead Sponsor
- Kyowa Hakko Kirin Co., Ltd.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- 165
Inclusion Criteria
Subject has voluntarily signed the written informed consent form to particiate in this study
-Subject has completed the week 52 evaluation of Study 003 or 004.
Exclusion Criteria
-Subject has had a serious infection, defined as requireing systemic treatment with antibiotics or antivirals (excluding oral administration)
-Subject has been judged to be ineligible for participation in the study by the investigators/subinbestigators
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method